XML 83 R51.htm IDEA: XBRL DOCUMENT v2.4.1.9
License Obligations - Evonik definitive Development and Exclusive License Option Agreement - Additional Information (Detail) (USD $)
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Research and Development Arrangement, Contract to Perform for Others [Line Items]      
Research and development expense $ 34,285,000us-gaap_ResearchAndDevelopmentExpense $ 53,327,000us-gaap_ResearchAndDevelopmentExpense $ 35,366,000us-gaap_ResearchAndDevelopmentExpense
Definitive Development And Exclusive License Option Agreement[Member]      
Research and Development Arrangement, Contract to Perform for Others [Line Items]      
Number of license agreements granted 2bdsi_NumberOfLicenseAgreement
/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis
= bdsi_DefinitiveDevelopmentAndExclusiveLicenseOptionAgreementMember
   
Development services fees received 2,160,000bdsi_DevelopmentServicesFeesReceived
/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis
= bdsi_DefinitiveDevelopmentAndExclusiveLicenseOptionAgreementMember
   
Research and development expense $ 400,000us-gaap_ResearchAndDevelopmentExpense
/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis
= bdsi_DefinitiveDevelopmentAndExclusiveLicenseOptionAgreementMember